Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

61.59
Delayed Data
As of Sep 22
 -12.11 / -16.43%
Today’s Change
60.97
Today|||52-Week Range
172.75
-43.31%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Pruzanski Mark E
President & Chief Executive Officer
Sale6/26/201718,763$130.46$2.4M-52.74%
Pruzanski Mark E
President & Chief Executive Officer
Sale6/26/20177,816$129.49$1.0M-52.74%
Pruzanski Mark E
President & Chief Executive Officer
Sale6/26/20175,893$131.18$773.0K-52.74%
Pruzanski Mark E
President & Chief Executive Officer
Sale6/26/20175,485$132.54$727.0K-52.74%
Shapiro David A /altair/
Sale9/26/20162,659$164.76$438.1K-62.90%
Pruzanski Mark E
President & Chief Executive Officer
Buy6/26/201740,000$8.67$346.8K-52.74%
Pruzanski Mark E
President & Chief Executive Officer
Sale1/03/20172,802$103.92$291.2K-40.17%
Pruzanski Mark E
President & Chief Executive Officer
Sale6/26/20172,043$133.07$271.9K-52.74%
Shapiro David A /altair/
Sale10/03/20161,350$163.06$220.1K-62.07%
Pruzanski Mark E
President & Chief Executive Officer
Sale7/03/20171,434$121.78$174.6K-49.62%
Page of 9